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ABSTRACT
INTEGRATING BIOLOGICAL PATHWAYS AND
GENOMIC PROFILES WITH CHIBE 2
Merve C¸akır
M.S. in Computer Engineering
Supervisor: Assoc. Prof. Dr. Ug˘ur Dog˘ruso¨z
July, 2013
Biological pathways store information about spatial and temporal organiza-
tion of interactions taking place in an organism. They hold valuable information
that can assist scientific community in understanding the details of a particular
mechanism or deciphering the reasons of disruption when the system goes wrong.
However, extracting knowledge from these pathways is not trivial as they can be
huge and complicated. Additionally, simple visualization of pathways will only
reveal limited knowledge, whereas their integration with experimental results can
identify distinct and intriguing relationships. Therefore, it is critical to have tools
that are specialized in analyzing and understanding biological pathways.
ChiBE is one such tool that can visualize, manipulate and analyze pathway
data stored in BioPAX format. While preparing the second version of the tool,
there have been improvements regarding pathway searches, high throughput data
integration, and database connections. Visual notation has also been updated in
order to follow standards in visualizations defined by the SBGN community.
Previously defined pathway query algorithms have been adapted to be com-
patible with the BioPAX model. New query types have also been designed to
offer a wider range of options. With these queries, ChiBE now offers a variety of
ways of pathway decomposition and thorough analysis of complex pathway views.
There has also been improvements in integration of high throughput experi-
mental results. To offer easy access to expression microarrays, a gateway to the
GEO database has been added. The cBio Cancer Genomics Portal is also now
reachable within ChiBE in order to obtain information about genomic status of
various cancer cells. After simply asking for an identifier of a particular experi-
ment, ChiBE retrieves the results from databases and then integrates them with
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the available pathway view through color codes. Furthermore, a connection to
DAVID database is available, in case users want to annotate a list of genes with
respect to biological terms associated with them.
With these new features and improvements, ChiBE 2 has become a compre-
hensive tool that offers a wide range of analysis options with a genomics-oriented
workflow to deepen our understanding of biological pathways.
Keywords: Computational biology, bioinformatics, pathway informatics, pathway
visualization, genomics.
O¨ZET
BI˙YOLOJI˙K YOLAKLARIN VE GENOMI˙K
PROFI˙LLERI˙N CHIBE 2 YOLUYLA ENTEGRASYONU
Merve C¸akır
Bilgisayar Mu¨hendislig˘i, Yu¨ksek Lisans
Tez Yo¨neticisi: Doc¸ent Dr. Ug˘ur Dog˘ruso¨z
Temmuz, 2013
Biyolojik yolaklar bizlere bir organizmanın devamlılıg˘ını sag˘layan et-
kiles¸imlerin mekansal ve zamansal organizasyonu hakkında bilgiler sunabilir. Bu
yolaklar, bilim du¨nyasına o¨nemli bir biyolojik mekanizmayı daha detaylı anla-
masında veya sistemde go¨zlenen bir sorunun sebebinin anlas¸ılmasında o¨nemli
katkıda bulunabilirler. Fakat yolaklar bu¨yu¨k ve karmas¸ık olabilecekleri ic¸in, on-
lardan bilgi elde etmek basit bir is¸lem deg˘ildir. Ayrıca sadece go¨rselles¸tirme odaklı
analizler bizlere sınırlı miktarda bilgi sag˘layabilirken, bu go¨rsellerin deneysel
sonuc¸lar ile entegre edilmesi farklı ve ilginc¸ etkiles¸imleri ac¸ıg˘a c¸ıkarabilir. Bu ne-
denle, biyolojik yolakların analizi ve daha detaylı anlas¸ılması u¨zerine yog˘unlas¸mıs¸
yazılım arac¸larına sahip olmanın o¨nemi bu¨yu¨ktu¨r.
ChiBE, BioPAX formatında saklanan yolak verilerinin go¨rselles¸tirilmesi,
du¨zenlenmesi ve analizi u¨zerine odaklanmıs¸ bir yazılım aracıdır. Yazılımın ikinci
versiyonu gelis¸tirilirken c¸izge u¨zerinde aramalar, yu¨ksek c¸ıktılı deney sonuc¸larının
entegrasyonu ve veritabanı bag˘lantılarının sag˘lanması u¨zerine yog˘unlas¸an ek-
lemeler yapıldı. Ayrıca ChiBE’nin go¨rsel sembolleri de SBGN tarafından be-
lirlenmis¸ standartları takip edecek s¸ekilde gu¨ncellendi.
Daha o¨nceden tanımlanmıs¸ olan yolak sorgulama algoritmaları BioPAX mo-
delleri u¨zerinde kullanılabilecek s¸ekilde uyarlandı. Bunlara ek olarak yeni yolak
sorgulama tu¨rleri de gelis¸tirildi. Bu algoritmaların eklenmesiyle birlikte, ChiBE
artık yolakları daha ku¨c¸u¨k parc¸alara ayrıs¸tıran ve karmas¸ık c¸izgelerin detaylı
analizini sag˘layan birc¸ok farklı yola sahip oldu.
Yu¨ksek c¸ıktılı deneylerin sonuc¸larının c¸izgeler ile entegrasyonu ile ilgili de
bazı iyiles¸tirmeler yapıldı. Mikrodizi deneyleri sonuc¸larına kolay eris¸im sun-
mak ic¸in GEO veritabanına ulas¸ım noktası eklendi. Ayrıca, kanser hu¨crelerinin
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genomik durumu hakkında bilgi sunmak ic¸in ‘cBio Cancer Genomics Portal’ı
da ChiBE ic¸erisinden eris¸ilebilir hale getirildi. Kullanıcıdan deney verisini be-
lirleyen bilgiyi aldıktan sonra, ChiBE o¨ncelikle istenilen deneyin sonuc¸larını ve-
ritabanından elde eder ve ardından bu sonuc¸ları c¸izge ile renk kodları kullanarak
entegre eder. Bunlara ek olarak, DAVID veritabanına da kolay bir eris¸im sunul-
maya bas¸landı. Bo¨ylelikle, kullanıcılar bir gen listesini bilinen biyolojik terimlerle
es¸les¸tirme s¸ansına sahip olacaklar.
Bu yeni o¨zellikler ve iyiles¸tirmelerle birlikte ChiBE 2 genomik odaklı is¸ akıs¸ına
elveris¸li, genis¸ c¸apta analiz sec¸enekleri sunan ve biyolojik yolaklar hakkındaki bilgi
birikimimizi derinles¸tirebilecek kapsamlı bir yazılım aracı haline geldi.
Anahtar so¨zcu¨kler : Hesaplamalı biyoloji, biyoenformatik, yolak go¨rselles¸tirmesi,
genomik.
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Chapter 1
Introduction
1.1 Biological Pathways
Cells, the tiny building blocks of living organisms, can be seen as a huge factory
filled with metabolites, proteins or nucleic acids that are in constant interaction
with each other to keep the factory running. Understanding details of these mech-
anisms and sets of interactions in its full context is a challenging task. Therefore
rather than dealing with the whole set, researchers opted to divide cellular events
into smaller yet meaningful pieces. This smaller set of interactions are chosen
to be bound together as they contain molecules having causal relationships with
each other, in the end to accomplish a biological event. This set of meaningful
interactions is called pathways [1].
With the advances in molecular biology field, our knowledge in cellular events
and pathways has vastly increased. With ongoing experiments, missing pieces in
cellular machinery are being completed which leads to a more and more compre-
hensive state of knowledge in biological pathways. After deciphering the com-
ponents of a pathway, the next step is more detailed analysis of this pathway in
order to fully understand its function, discover its relationship with other path-
ways or study the possible outcomes when the machinery of the pathway goes
wrong. This means that the focus of research is now diverting from gene level
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to pathway level, which mandates the development of approaches that will aid
scientific community in this quest.
One of the first steps of pathway analysis is the visualization of a pathway.
The details of a pathway deciphered through experiments can be transmitted to
other researchers through textual descriptions (Figure 1.1(a)). However, long and
complicated texts can make it harder to follow the interaction path and extract
the critical points of the pathway. Instead, a visual representation can ease this
communication. In Figure 1.1(b), we see a visualization obtained from KEGG
database [2] of the textual description seen in Figure 1.1(a). With this visual
representation, it is much easier to follow the flow of events. Also thanks to
spatial organization, it is only trivial to find a subset of interactions, whereas one
would have to scan the whole text to find the same information. This is just one
instance reflecting the importance of proper choice of representation in easing the
pathway analysis steps.
Unfortunately, this simple conversion of text into a diagram is not enough.
One of the biggest problems associated with this is the fact that it is a static
image. This means that you are limited to knowledge offered by the image and
you cannot expand it or focus on a subpathway of the original image. Therefore,
the advantages of this static image representation is limited. We need further
improvements in pathway visualization approaches in order to be able to perform
progress in research through them. There are many different approaches that
can be followed to convert these static images into better analysis devices. For
instance, being able to crop a pathway to generate a smaller subpathway or hiding
unnecessary nodes and edges can enable researchers to focus on the pieces of a
large pathway that attracts their attention most [3, 4, 5]. Alternatively, query
operations can be performed on the pathway or on pathway databases [6, 7].
With such options, users can start with a set of molecules in hand and search
them and their interactions in the pathway in order to generate a subpathway
focusing on the molecules of interest and their relationships. Multiple different
layout options can be offered, which can help the user arrange the topology of
image in hand in order to understand the spatial organization of the pathway
better [4, 5].
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(a) Textual description of a biological pathway
(b) Visual representation of the same pathway
Figure 1.1: A sample pathway obtained from KEGG database
3
Figure 1.2: A sample pathway image integrated with microarray experiment re-
sult. The color codes are based on the experimental values each gene is associated
with.
All these exemplify the cases of extension of analysis through changes in path-
way structure or topology. Another trail of approach is the integration of exper-
iment results with pathway knowledge [3, 6, 8]. Traditional way of analyzing
high throughput experiment results is gene-centric. For instance, to make use
of results of microarray experiments, researchers tend to identify genes that are
significantly differentially expressed from rest of the gene set. Although this re-
turns a set of genes that can be building blocks of new hypotheses, one can gain
a greater amount of knowledge from these experiments if pathway knowledge is
also added to the equation. Integrating high throughput experiment results with
pathways generates new pathway images that not only reflect the interactions be-
tween molecules but also their experimental conditions (Figure 1.2). Researchers
will be able to see whether there are clustered overexpressed molecules or if there
is a dysregulated transcription factor causing differential expression in molecules
in its downstream. With this approach, we can increase the amount of knowledge
we can extract from both pathway information and experiment results. The set
of experiments that is suitable for this integration is not limited to microarray
experiments. Sequencing experiments that reflect the alteration status of genes
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or copy number variation experiments are some of other cases that possess the
advantage of being analyzed at a pathway level.
Pathway visualization and analysis field is still open to developments that
includes but not limited to the ones discussed above. Answering the needs of the
field in these respects is an important step in ensuring full knowledge acquisition
from pathway information reconstructed from biological experiments.
1.2 Standards for Pathway Data Exchange
The shift of focus from gene-centric approaches to pathway-centric approaches
has resulted in a rapid increase in the amount of available pathway data. Lots
of different research groups focused on reconstructing pathways from biological
experiments and knowledge. One problem associated with this expansion is the
lack of compatibility between different curators. Due to lack of a standard format
and notation for generation of pathway data, different research groups have come
up with different ways of storing and representing pathway data. This builds a
barrier in front of the hopes of combining data from different resources in order
to build a comprehensive resource. It also makes it harder for users to utilize this
data as they will need to adjust to a new way of representation every time they
want to use data from a different source.
To overcome these problems, some community efforts have emerged to stan-
dardize pathway data storage and representation. One of them is Biological
Pathway Exchange (BioPAX), whose objective is to develop a standard format
for storing and sharing pathway data [1]. This community effort has been ini-
tiated in order to define a standard syntax for representation of pathway data,
which will in turn remove the barriers in collecting, storing and sharing them.
The developed syntax is based on OWL (Web Ontology Language). The initial
stages of the project, called Level 1, only supported metabolic pathways. Then
each level expanded the capabilities of the standard. Level 2 added signaling
pathways and molecular interactions on top of metabolic pathways. The latest
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version, which is Level 3, can additionally represent gene regulatory networks and
genetic interactions. With this standardization, one of the biggest communication
barrier between pathway researchers has been eliminated.
The followup to a standard in storage format is a central database storing and
offering pathway data in that format. Pathway Commons project has started to
answer this demand [9]. The main aim of this effort is to build a central hub for
reaching pathway data stored in BioPAX format. Pathway data that is already
stored in several different databases are collected together and integrated to be
stored in one database. Pathway Commons offers different ways of reaching to
this data. Users can simply use their web site in order to search for specific
pathways. Download site can be used for bulk downloads of integrated set of
pathway data and web service is offered to software developers as a connection to
the database that can be used in their software. With these offerings, researchers
can easily reach to a comprehensive set of already available pathway data in the
standard format of BioPAX.
The problem of storing pathway data in a standard format and database has
been solved, yet there still are points needing consideration: the visualization
of this standard data. BioPAX and Pathway Commons have helped researchers
share pathway data with each other without considering compatibility or under-
standability problems. However there was still no standard in visualizing this
data. If everyone was to come up with their own notation for visualization, then
it would be problematic for the end user to familiarize with all these different
notations. Thus a standard way of representation was required and Systems Bi-
ology Graphical Notation (SBGN) project has been born for this reason [10]. The
purpose of this effort is to develop standard notations for visualizing biological
processes. SBGN community have developed three different languages for rep-
resentation of biological pathways: process description, entity relationship and
activity flow. Figure 1.3 shows an example for process description language, in
which the events observed in a neuro-muscular junction are visualized with a fo-
cus on interactions taking place [11]. These languages form a comprehensive and
unambigous way of representing pathway data.
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Figure 1.3: A sample SBGN process description map describing the events oc-
curring in a neuro-muscular junction.
All these efforts have helped significantly in building a pathway research com-
munity that stores, shares and represents pathway data in a centralized and
understandable way. This in turn has helped software developers to stop being
concerned about these matters and to start focusing on developing tools that will
answer the needs of pathway informatics field that has been discussed above.
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1.3 Contribution
ChiBE is an open source tool that specializes in visualization and analysis of
pathway data stored in BioPAX format [3]. Its first version is capable of visu-
alizing BioPAX Level 2 pathway data, supporting on-demand layout of loaded
pathway views. The tool offers various features that can help researchers in their
analysis of BioPAX formatted pathways, including cropping subpathways, high-
lighting particular elements in pathways or creating simple interaction views. It
can access Pathway Commons to reach the neighborhood of a specific molecule
and perform a mapping between high throughput experiments and pathway view
through user input.
Although it offers such a wide range of features, there is still room for im-
provement to make ChiBE more useful to scientific community. We wanted to
improve the tool in such a way that it will offer a variety of features that can
help the researchers to analyze BioPAX formatted pathway data from different
perspectives. The remainder of this thesis will focus on new methods and im-
provements to existing methods and their implementation in ChiBE, which can
be summarized as follows:
• Breadth-first search algorithm has been tailored to the specific structures
stored in BioPAX format. Using this search approach, previously defined
query algorithms have been implemented [12]. (Chapter 3)
• New queries have been designed and implemented to offer users the flex-
ibility of searching a pathway model based on a set of biological entities.
(Chapter 3)
• A one-click access to GEO database [13] has been added to ease the inte-
gration of expression microarrays with pathway view. (Chapter 4)
• Integration of cancer genomics data with pathway view based on alteration
ratios of genes is now offered through the communication with the cBio
Cancer Genomics Portal [14]. (Chapter 4)
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• Connection to DAVID database [15] is supplied in order to offer a way of
annotating and understanding a particular list of genes more thoroughly.
(Chapter 5)
• Visual notation of ChiBE is updated in order to follow guidelines specified
by SBGN [16]. (Chapter 5)
• Support for visualization of Level 3 BioPAX models is now provided, on
top of the existing support for Level 2 models.
After discussing these improvements in detail in the specified chapters, Chap-
ter 6 will focus on examples related to these features in order to highlight their
use cases. Chapter 7 will conclude the thesis along with a discussion on future
directions.
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Chapter 2
Background Information
2.1 Graphs
A graph G can formally be defined as a pair of sets (V,E), where V stands for the
non-empty set of nodes and E stands for the set of edges. Edge set E contains
elements that connects nodes found in set V . e = {a, b} represents an edge joining
node a and node b. Nodes a and b are incident to edge e. Additionally, the two
nodes are neighbors of each other.
A non-empty subgraph P = (V ′, E ′) will be called as a path, if V ′ and
E ′ follow the upcoming criteria. The node set V ′ needs to be composed of
{v0, v1, v2, ..., vn−1, vn}, with v0 and vn being the path’s endpoints. The edge
set E ′ will be composed of edges connecting the nodes in V ′, which are repre-
sented as {v0v1, v1v2, ..., vn−1vn}. The length of path P is equal to the size of
edge set E ′. For a path to be directed, all of the ordered edges have to have the
same direction. A cycle will be formed if a path’s endpoints are the same node n.
Relations between nodes based on their location on the path can also be defined.
Let node n0 be the starting point of a directed path and node nk be its ending
point. Then this means that node nk is in downstream of node n0 and node n0 is
in upstream of nk. [12]
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Paths can also be found between sets of nodes. Consider two node sets V1 and
V2. If only the endpoints of a path is found in V1 and V2 and no other intermediate
nodes belong to these two node sets, then the path can be named as V1−V2 path.
Compound graphs refer to the cases where a node in the graph may contain
other nodes and edges within it. On top of the sets of nodes V and edges E, a
compound graph is also defined by a set of inclusion edges F . Inclusion set F is
used to represent nesting relationships between a compound node and the node
found within it, which can be called as child node.
2.2 Pathways
The realization of these concepts in pathway visualization context can be seen in
Figure 2.1, which represents a sample pathway image from ChiBE. As it can be
seen, a pathway view consists of nodes and the interactions between them.
Figure 2.1: A sample graph from ChiBE
ChiBE displays given pathway data with compound graphs and compound
11
nodes are used for two different purposes. They can either represent complexes
composed of multiple entities, such as “MEK1:ERK-1” complex, or compartments
corresponding to cellular localizations, such as cytoplasm. In the cases of com-
plexes, child nodes of a compound node can only be other physical entity nodes.
However, children of compartment compound nodes can be any of them, including
other compound nodes. The remaining elements of node set are visualized with
simple nodes and they can either be a distinct state of a physical entity, drawn
with rounded rectangles or transitions between them, drawn with gray squares.
Transitions signify the cellular events involving these biological entities, including
complex formations, transportations or reactions such as phosphorylation.
The elements of edge set connect transitions and states interacting with them
based on the type of relationship between these nodes. There are different types
of edges used for different purposes, such as substrate, product, and effector edges.
Black edges are used to represent substrate and product relationships, whereas
green edges signify activating effectors and red ones are used for inhibitory effector
edges. There are cases where more than one effector molecule is present or where
an effector edge targets another effector edge. To represent these cases, control
nodes drawn with gray diamonds are used. The complete set of node and edge
types supported by ChiBE can be seen in Figure 2.2.
Figure 2.2: Different glyphs supported by ChiBE to represent different biological
entities and relationships [35]
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An example of a path can also be seen in Figure 2.1, which is highlighted
in yellow. The start point of this path is the complex phospho-ERK-1:MEK1
and after going through two reaction nodes and a physical entity node MAP2K1,
the path ends at the complex MEK1:ERK-1. In this graph, p-MEK1 is in the
downstream of CDK1 and MEK1 is in the upstream of p-MEK1.
2.3 Network Traversal and Querying
2.3.1 Breadth-First Search
Breadth-first search [17] is a technique that has been developed to perform
searches on graphs with respect to a set of nodes. Its main purpose is to identify
the nodes in the graph that can be reached from the nodes found in a distinct
source set. The basic logic of breadth-first is traversing every reachable node
at distance k before moving onto the nodes found at distance k + 1. A sample
breadth-first search algorithm is given in Algorithm 1.
Algorithm 1 BFS(S, T , dir, limit)
1: for all node n ∈ S do
2: n.color ← gray
3: n.label(dir)← 0
4: Q← ∅
5: R← ∅
6: Q.enqueue(S)
7: while Q 6= ∅ do
8: current← Q.dequeue()
9: if current.label(dir) < limit and current /∈ T then
10: N ← current.neighbor(dir)
11: for all node neigh ∈ N do
12: if neigh.color = white then
13: neigh.color ← gray
14: neigh.label(dir)← current.label(dir) + 1
15: Q.enqueue(neigh)
16: current.color ← black
17: R← R ∪ {current}
18: return R
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The algorithm requires a source set of nodes (S) and a direction dir deter-
mining whether the search should traverse the graph moving forwards from the
source nodes or backwards. It also asks for a limit, which is an upper bound for
a reachable node’s distance from the source set. A target set of nodes (T ) can
also be defined and when the traversal reaches to an element from this set, it
does not go further in that direction. To prevent passing over a particular node
multiple times, a coloring scheme is used in breadth-first search implementations.
At the beginning all nodes are white, except for the ones in source set. They
have the color gray as it represents the nodes that are currently in queue. Once
a node is reached for the first time, its color is converted from white to gray
and it is placed in the queue. black is reserved for nodes that have already been
processed. The complexity of this algorithm is O(|V |+ |E|), linear in the number
of nodes and edges.
This search algorithm will become useful when we need to move through a
graph in order to perform queries focusing on a set of nodes found in the graph.
2.3.2 Neighborhood Query
Finding the nodes surrounding a particular node is one of the first aspects that
comes to mind while trying to extract knowledge from that node using the given
graph. Therefore one of the basic uses of graph traversal algorithms is querying
the neighborhood of a particular node [12].
Details of a proposed neighborhood query algorithm can be seen in Algo-
rithm 2. The algorithm requires a set of source nodes (S), a traversal direction
(dir), and a stop distance (limit). The search can be done in either downstream
or upstream direction of source nodes or alternatively a combined search can
be performed to get the complete neighborhood. If that is the case, two differ-
ent breadth-first searches are performed, one in forwards and one in backwards
direction. The target set of these searches are empty because there is no destina-
tion; the search is simply bounded by the distance from the source nodes. The
algorithm runs in O(|V |+ |E|) time.
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Algorithm 2 Neighborhood(S, dir, limit)
1: R← ∅
2: if dir = fwd or dir = both then
3: R← R ∪ BFS(S, ∅, fwd, limit)
4: if dir = rev or dir = both then
5: R← R ∪ BFS(S, ∅,rev, limit)
6: return R
When implemented, this algorithm can easily be used to identify the set of
nodes that are found within a certain distance from the set of source nodes. This
way we can get more information about the characteristics of surroundings of
these source nodes.
2.3.3 Paths Of Interest
When you have two different sets of nodes of interest, the directed paths between
them whose endpoints are these two sets respectively can hold valuable informa-
tion about the flow of interaction between these sets. Similar to neighborhood
query, a breadth-first traversal can be used for identification of these paths. The
traversal needs to start from one of the sets and continue until it finds all the
paths arriving to the nodes of the second set [12].
Algorithm 3 PathsOfInterest(S, T , limit)
1: C ← BFS(S, ∅, fwd, limit)
2: ResetColor(C)
3: C ← C ∪BFS(T, ∅,rev, limit)
4: R← ∅
5: for all node n ∈ C do
6: if n.label(fwd) + n.label(rev) ≤ limit then
7: R← R ∪ {n}
8: return R
Algorithm 3 reflects the basics of a sample algorithm that follows the proposed
reasoning to solve this problem. The algorithm requires a source set S from which
the paths will start, a target set T to which the paths will converge and a distance
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limit specifying the distance between source and target nodes. At first, a breadth-
first search is performed with source set of nodes in forwards direction. This will
be followed by a backwards directed search from target set of nodes. The resulting
set of nodes will be composed of the ones whose sum of distance labels from these
two queries does not exceed the search limit. This algorithm’s time complexity
is O(|V |+ |E|). With this approach, we will be able to recover paths originating
from a set of nodes and ending at a different set of nodes whose length is smaller
than a predefined threshold.
2.3.4 Graph Of Interest
A special version of the described Paths of Interest query approach can be used to
solve a more general problem. Instead of identifying paths following a particular
direction, we can identify all of the paths found between the elements of a set
of nodes [12]. Rather than dividing the set into start point nodes and end point
nodes, in this case we look for a comprehensive set of paths found within all
elements of a single set.
Algorithm 4 simply shows how Paths of Interest query can be used for this
query type. Rather than specifying a source set and target set, a single set of
nodes is given to the algorithm as both source and target sets. As a result, we
will be searching for the paths that start at one of the source nodes and ends at
another source node. A search limit is also required to bound the length of the
recovered paths. The complexity of this algorithm is clearly the same as Paths
Of Interest, which is O(|V |+ |E|).
Algorithm 4 GraphOfInterest(S, limit)
1: return PathsOfInterest(S, S, limit)
When Paths Of Interest query is run on the pathway in this way, we will be
able to recover the ways to traverse the graph between the given set of nodes,
irrespective of the direction.
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2.3.5 Common Stream Query
Each node’s neighborhood holds special information for that particular node,
however there may be even more valuable information hidden in the shared neigh-
borhood of a set of nodes [12]. Searching for the elements that are located in the
common downstream of a set of nodes will signify the point that the paths of these
different nodes merge with each other. Nodes in the upstream that are commonly
shared can be used to identify the point of divergence of different paths.
Algorithm 5 CommonStream(S, dir, limit)
1: C ← ∅
2: R← ∅
3: for all node n ∈ S do
4: BFSRun← BFS({n} , ∅, dir, limit)
5: for all node res ∈ BFSRun do
6: res.reached← res.reached + 1
7: C ← C ∪ BFSRun
8: ResetLabel(BFSRun, dir)
9: ResetColor(BFSRun)
10: for all node c ∈ C do
11: if c.reached = S.size then
12: R← R ∪ {c}
13: return R
Algorithm 5 explains the details of the algorithm that has been designed to
find the upstream or downstream elements that are shared by a set of nodes.
For every node in the source set S, first a breadth-first search is performed in
the direction specified (dir) and bounded by the search limit. The difference of
this algorithm from the previously discussed ones will be the way of determining
final result set. For each node, a count called reached is kept. This reflects the
number of times a particular node is found to be in the result set of breadth-first
searches. So after each search run, the reached count of every node in the result
set is incremented. In the end, only the nodes whose reached count is equal to
the size of source set are placed in the result set. This is because we only want to
recover the nodes that can be reached through every single element of the source
set. So, in the end obtaining nodes fulfilling this criteria will return us the nodes
that are common to the traversal paths of source nodes in the specified direction.
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The run time complexity of this algorithm is O(|S| × (|V |+ |E|)).
2.4 Related Work
This section will focus on the tools that have been developed for enhancing the
visualization and analysis of pathway data in order to give an insight about the
current status of the field.
2.4.1 Cytoscape
Cytoscape is a generic visualization tool that can be used to draw, visualize and
analyze networks [18]. The tool is useful for purposes of wide range of fields,
ranging from computational biology to social networks. There are numerous
different plugins that can extend and specialize functions of the tool.
For computational biology purposes, core Cytoscape offers importing of net-
works in lots of different file formats including .owl for BioPAX, .sbml and .sbgn
for SBML and .xml files. Additionally networks can be obtained from online
databases such as Pathway Commons. For the visualization of these networks,
Cytoscape offers many different layout algorithms, such as circular, grid, spring
embedded or sugiyama layouts. Figure 2.3(a) displays a network obtained from
Pathway Commons database, laid out with degree sorted circle layout.
One of the Cytoscape plugins called BiNoM [19] can be used to analyze and
manipulate biological networks stored in standard systems biology file formats.
The plugin can be used to import and export files in BioPAX Level 3 and SBML
format. It also offers topological analysis, such as centrality calculations. A sam-
ple BioPAX model’s representation with BiNoM can be seen in Figure 2.3(b).
The difference in visualization preferences of Cytoscape and BiNoM is prominent.
Whereas core Cytoscape only offers a simple interaction network displaying the
relationships between molecules, BiNoM offers a hierarchical pathway structure
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(a) A sample view from Cytoscape (b) Sample pathway view obtained with Cytoscape plu-
gin BiNoM
Figure 2.3: Sample pathway views obtained with Cytoscape
along with reactions connecting different molecules, which reflects more informa-
tion about the events occuring in the pathway.
Examples of other plugins include MetScape [20], which can be used to ana-
lyze high throughput gene expression and metabolomics data. KeyPathwayMiner
[21] also has a similar purpose; it is specialized in identifying significant subnet-
works within a biological network by making use of gene expression data. En-
richmentMap [22] can be integrated with Cytoscape if a user wants to see the
results of gene set enrichment analysis as a network. These examples show that
users can install different plugins in order to customize Cytoscape and make it
compatible with their needs.
2.4.2 PathVisio
PathVisio is an open source tool for visualization and editing of biological path-
ways [23]. The tool can import and export pathways stored in XML files and
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.mapp files - which is a format specifically related to GenMAPP [24]. Addi-
tionally, pathway images can be exported in .pdf, .png, .svg and .tiff formats.
Users are not only dependent on the already available pathway data; generation
of pathways from scratch is also possible through drawing options offered by the
tool.
The visual notation of PathVisio is quite unique, as seen in Figure 2.4. The
tool uses specialized structures to reflect extra information easily - such as the
compartmentalization of different environments through extra rectangular nodes
seen in Figure 2.4(a). Another sample visualization can be found in Figure 2.4(b),
in this example the use of significantly different edges to connect interacting nodes
draws the attention of the user.
(a) (b)
Figure 2.4: Sample pathways obtained with PathVisio
Apart from visualizing the biological pathways, PathVisio can also integrate
expression data with the pathway image. User is required to perform the mapping
between expression data file and the structure of integration mechanism. After
that, the data is integrated with the view through color coding.
PathVisio’s functionality can be expanded through available plugins. Cur-
rently, there are plugins that can be installed to enable data import and export
in BioPAX Level 3 or to enable drawing pathway views with SBGN notation.
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2.4.3 CellDesigner
CellDesigner is another modeling and visualization tool for biological networks
[25]. SBML files are the format that has been preferred by CellDesigner, it can
import and export pathway data stored in .sbml and .xml files. Public databases
such as BioModels and PANTHER can also be used to import pathway data.
Similar to PathVisio, it is possible to create your own pathway models through
drawing capabilities offered by CellDesigner.
CellDesigner uses a customized visual notation that is quite similar to SBGN
specifications (Figure 2.5(a)). However, it is also possible to convert the view
into a version that completely follows SBGN guidelines (Figure 2.5(b)). The tool
offers multiple different automatic layout options, including but not limited to
hierarchic, circular, tree and organic layouts. Users can choose any of them to
optimize the pathway view’s organization according to their needs.
The connections offered to external databases are not limited to pathway
data import. Upon selection from the view, one can choose to connect to many
different databases such as PubMed, Entrez Gene, UniProt or MetaCyc to get
more information about the selected node.
CellDesigner is also extensible through plugins. For instance, BioPAX Export
plugin can be used to export pathway models in BioPAX Level 3 format. An-
other plugin is available for integrating microarray and proteomics data with the
pathway.
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(a) Default visualization notation of CellDesigner
(b) The same view, this time with SBGN notations
Figure 2.5: Sample pathways obtained with CellDesigner
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Chapter 3
Graph Queries
With the advances in biological research, the scientific community’s knowledge
about biological relationships and pathways have shown an increase at a signif-
icant pace. This in turn led to a significant increase in the knowledge stored in
pathway structures and databases. The scope and comprehensiveness of empir-
ical pathway data are increasing each and every day. However, there are some
drawbacks of this obvious achievement. Increasing pathway size negatively im-
pacts the ease of analysis. Smaller pathway models can be extensively analyzed
after simply visualizing it. As the size of pathway gets bigger, it becomes more
and more complex to analyze a graph by simply looking at it due to the crowd-
edness of the resulting picture. This problem has motivated us to offer users a
way of easing analysis of complex graphs. For this purpose, we have implemented
graph query algorithms that will help the user to decompose the bigger picture
into smaller and meaningful parts.
In this chapter, these query algorithms will be discussed in detail. As ex-
plained in Section 2.3, graph querying algorithms require graph search approaches
to traverse the graph. The given breadth-first search algorithm however is not
directly applicable to pathway models visualized by ChiBE due to the nature
of BioPAX format. So initially, the way breadth-first search algorithm has been
adapted to overcome these problems will be discussed. Then, new graph querying
approaches depending on this algorithm that are targeted for biological pathways
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will be explained, which will be followed by the application of query algorithms
discussed in Section 2.3 to ChiBE through use of adapted breadth-first search
approach.
3.1 Adapting Breadth-First Search
While performing queries on pathway models, we can try to use the breadth-first
search given in Algorithm 1 in order to move through the pathway view and find
distances between physical entities. However, this is not as straightforward as it
seems. The regular BFS is a perfect match for graphs that contain one type of
node connected with one type of edge (Figure 3.1(a)). However, the graphs dis-
played with ChiBE are not that simple (Figure 3.1(b)). There are multiple types
of nodes and edges. For instance, there are physical entity nodes represented
with rounded rectangles and reaction nodes represented with gray squares. Dur-
ing our search, we only want to focus on the distances between physical entity
nodes, which means that there will be additional nodes between the nodes that
we are interested in, causing problems in the calculation of distances.
A
B C D
E F
(a) A sample graph (b) A sample BioPAX graph
Figure 3.1: Sample graphs to highlight the differences observed due to BioPAX
structure
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In the example seen in Figure 3.1(b), we see an alternating pattern between
physical entity nodes and reaction nodes. A physical entity node is followed by
a reaction node before connecting to the next physical entity node. BFS is still
applicable to this graph with a simple change, which is multiplying the given
distance limit with two. The kth physical entity from the source set will actually
be at 2k distance from the source due to the presence of reaction nodes and with
the multiplication, we will be searching within 2k distance boundaries and be able
to identify physical entities at k distance as desired. Unfortunately, this pattern is
not observed in all BioPAX models. There are cases where a reaction node is not
followed by a physical entity node, as highlighted in Figure 3.2(a). Additionally,
there is a special type of edge that represents generic relationships between nodes,
which refers to the cases where a set of physical entities can be represented with
a single generic version of them. In these cases, a physical entity node is directly
connected to another physical entity node omitting a reaction node in between
(Figure 3.2(b)). As a result of these special cases, we cannot apply the regular
breadth-first search algorithm to calculate the distance between physical entity
nodes.
(a) Control node (b) Generic edge
Figure 3.2: Structures of BioPAX that causes problems during application of BFS
To overcome this problem, we have come up with a new way of calculating the
distances while traversing the graph (Figure 3.3). As we want to see the distance
between physical entities, we will be updating the distance labels only when we
interact with a physical entity node - which from now on will be called as breadth
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node. If we are traversing the graph in forwards direction, then the distance
label will be updated only if the search enters a breadth node (Figure 3.3(a)).
While traversing in backwards direction, distance will be increased while leaving
a breadth node (Figure 3.3(b)). Exceptions to this will occur in case a generic
relationship represented with an equivalence edge is encountered (dashed edges
in Figure 3.3); if two breadth nodes are connected with an equivalence edge, then
they will have the same distance label. One node is the generic version of the
other, so we count them as equal in biological context and therefore give them
the same distance label to make them equal in graph context.
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(a) Labeling behavior while going forwards
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(b) Labeling behavior while going backwards
Figure 3.3: An alternative distance labeling approach designed to overcome the
problems
The updated breadth-first search algorithm using the described labeling ap-
proach is explained in detail in Algorithm 6. This BFS algorithm requires the
following four inputs to be specified: a source set of nodes (S), a target set of
nodes (S), direction of traversal (dir), and stop distance (limit).
The algorithm starts with usual task of source set handling. The nodes in
the source set are added to the queue after updating their color to gray. First
important step after that is deciding the distance of the edge that comes out
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Algorithm 6 Updated-BFS(S, T , dir, limit)
1: for all node n ∈ S do
2: n.color ← gray
3: n.label(dir)← 0
4: Q← ∅
5: R← S
6: Q.enqueue(S)
7: while Q 6= ∅ do
8: current← Q.dequeue()
9: for all edge e of current going dir do
10: R← R ∪ {e}
11: if (dir = fwd) or (current is not breadth-node)
or (e is equivalenceEdge) then
12: e.label(dir)← current.label(dir)
13: else
14: e.label(dir)← current.label(dir) + 1
15: neigh← e.otherEnd(dir)
16: if neigh.color = white then
17: if (neigh is not breadth-node) or (dir 6= fwd)
or (e is equivalenceEdge) then
18: neigh.label(dir)← e.label(dir)
19: else
20: neigh.label(dir)← e.label(dir) + 1
21: R← R ∪ {neigh}
22: if neigh /∈ T and (neigh.label(dir) < limit
or neigh is not breadth-node) then
23: neigh.color ← gray
24: if neigh is breadth-node then
25: Q.enqueue(neigh)
26: else
27: Q.addF irst(neigh)
28: else
29: neigh.color ← black
30: current.color ← black
31: return R
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of dequeued node in the direction of traversal. First change to regular BFS
is observed at this point (Line 11) in order to follow the new distance labeling
approach. The required checks are performed in order to decide whether to update
the distance label. A similar check is again performed at Line 17, this time in
order to decide the distance label of neighboring node. Then this neighboring
node is placed into the queue, if it meets the required criteria. Placement of nodes
into the queue also requires extra attention. As seen in the if clause starting at
Line 24, breadth nodes are placed to the end of queue as expected, whereas non-
breadth nodes are added to the beginning of the queue. As a result, they are
processed immediately and breadth nodes connected to them are then added to
the end of queue as the next breadth of distance. After this process is performed
for each node in the queue, resulting set is returned which contains all the nodes
and edges that are within the boundaries of stop distance in the direction of
traversal.
With this traversal algorithm, we will be able to easily navigate through the
biological pathways, in time linear in the number of nodes and edges, and find
the distance of any physical entity node with respect to another physical entity
node. This will allow us to realize the query algorithms that will search specific
paths within the graph, which are discussed in detail in following sections.
3.2 Compartment Query
The division of a cell into specific organelles means that certain reactions are
confined to these subspaces, however there are also cases where a directed path
spans through several different organelles. For instance, some signaling pathways
start at the extracellular space after recognition of ligand through the receptor
and end at the nucleus after passing through cytoplasm. In ChiBE, organelles
are represented with compound nodes containing all the molecules and reactions
found within them, which means that we can use this compartmentalization to
search for paths that start at a specific organelle and reach to end at another
organelle.
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Compartment query can be seen as a special application of Paths Of Inter-
est query, described in Algorithm 3, and this is reflected in its design (Algo-
rithm 7). As a result, its time complexity is the same as Paths Of Interest, which
is O(|V |+ |E|). The query requires source compartments, target compartments,
and a distance limit. The breadth nodes in source compartments are extracted
to form the source set and the ones in target compartments form the target set.
Then simply a Paths Of Interest query is performed using these sets in order to
obtain the paths that originate in source compartments and terminate at target
compartments, that are not longer than the specified distance limit.
Algorithm 7 Compartment(Compartment S, Compartment T , limit)
1: S ← GetBreadthNodes(Compartment S)
2: T ← GetBreadthNodes(Compartment T )
3: return PathsOfInterest(S, T, limit)
Figure 3.4: An example result for Compartment query
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As an example to compartment query, Figure 3.4 represents all the paths
starting from nucleus and ending at cytoplasm, found in “Signaling by EGFR”
model. The paths generally represent transcription regulation events taking place
in nucleus, probably the end result of the cascade initiated by EGFR.
3.3 Path Iteration Query
There may be cases where a researcher has to deal with a huge and complex
pathway view and may not have a specific set of proteins that can be used as
a start point for decomposing such a huge graph. In that case, the previously
described query algorithms will not be applicable as they all require an initial set
of seed nodes. Considering such cases, another query has been designed, whose
basic aim is to extract meaningful paths in a complicated graph.
Algorithm 8 PathIteration
1: R← ∅
2: C ← ∅
3: for all breadth-node n do
4: C ← Updated-BFS({n} , ∅, fwd,∞)
5: for all node c ∈ C do
6: R← R ∪ {n, c, c.label(fwd)}
7: ResetLabel(C, fwd)
8: ResetColor(C)
9: sort R in order of decreasing labels
10: return R
The logic of this approach can be seen in Algorithm 8. In Line 4, we see that
the algorithm performs a downwards breadth-first search starting from every
single breadth node found in the pathway without a distance limit or target set.
Then, a result set is formed, which contains the start node, the node that has
been reached at the end of the search, and the distance between them. This
means that the query finds the pairwise paths between the breadth nodes found
in the graph. After this pair building step, resulting pairs are sorted in descending
order of distances. The reason behind this sorting step is that the longer the path,
the more information it will contain. The path obtained in this way will be long
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(a) A complex graph and the dialog listing the paths found within this pathway
(b) The selected option is visualized with the path highlighted in
yellow
Figure 3.5: An example result for Path Iteration query
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enough to display enough information for a random starting point of analysis and
short enough to yield a simpler network than the original one. The complexity
of this algorithm is clearly O(|V | × (|V |+ |E|)).
The actual result of the query is left to be decided by the user. A subset of
sorted list of pairs are displayed to the user (Figure 3.5(a)). The dialog first lists
all the paths with the longest distance. If their number is smaller than 10, then
the paths are added in decreasing order of distance until the number reaches to
10. Then only the path selected by the user is visualized (Figure 3.5(b)).
3.4 Adapting Query Algorithms
The graph querying algorithms explained in Section 2.3 can be useful tools in
analyzing biological pathways more deeply. Therefore, we have decided to imple-
ment them in ChiBE in order to offer a wider range of queries. The important
point to note here is that all queries will be making use of Updated-BFS given
in Algorithm 6, instead of the regular breadth-first search detailed in Algorithm 1.
With this simple adaptation, these query algorithms will become applicable to
the biological pathways. Upcoming sections will explain why one might need to
use these queries in context of a biological pathway and then give example results
to demonstrate their implementations.
3.4.1 Neighborhood Query
In biological pathways, neighborhood of a protein contains valuable information
related to that particular protein. From looking at the neighborhood, one can
learn the molecules regulating that protein, the remaining substrates of the re-
action that it is involved with or the proteins that are targeted by it. So we
have decided to implement Algorithm 2 in order to identify the neighborhood of
molecules of interest found in a pathway model.
An example result of this neighborhood query can be seen in Figure 3.6. In
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this query, 1-level neighborhood of HEY1 entity has been searched. The resulting
path is highlighted in yellow.
Figure 3.6: An example result for Neighborhood query
3.4.1.1 Entity vs State
At a given instance, a cell contains many different versions of a given molecule.
In nucleus, it can be found as its gene as part of DNA. It can be translated
into a protein and that protein may undergo different modifications, such as
phosphorylation or cleavage. Although they have very different properties from
each other, they still can be collected to form one type of biological molecule.
In BioPAX ontology [1], a distinction between these cases is applied. Each
different version is called a state of that molecule. Entity is used to describe
the collection of all states of a particular molecule. For instance, BRCA1 can be
used to describe an entity without specifying a particular modification or cellular
localization whereas phosphorylated BRCA1 is a state of BRCA1 entity.
While searching a given pathway model, breadth-first search can use either a
specific state as part of the given set of molecules or can collectively use all of
the states if an entity based search is preferred. Consider the query displayed in
Figure 3.6. In that example an entity based search is requested, therefore all of
the different versions of HEY1 entity is included in source set and the paths that
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are reached from any of them is included in the result. However for performing
the query seen in Figure 3.7, a specifically selected state of HEY1 is given as the
source. As a result, the path that can only be reached through the particular
state has been discovered at the end of the query.
Figure 3.7: An example result for state-based Neighborhood query
The choice between an entity-based and a state-based query can be made at
the starting point of the query. When the menu item offered in top menu bar
is used, user is required to specify entities for the query. There is also a pop-
up menu that is reachable through each node in the pathway view and it can
be used to specify a state-based query. Particular states of an entity that the
user is interested in need to be selected on the pathway view, then a query that
only uses these specified states is performed. With this distinction, users will be
enabled to focus on specific version of a given molecule without obtaining results
for unrelated states of an entity.
In the remaining of the query discussions, it will be assumed that entity-based
version is used unless specified otherwise.
3.4.2 Paths From To Query
Biological interactions tend to be targeted pathways, starting at a specific
molecule and ending at an effector molecule through intermediate pieces. Cas-
cade of proteins can transfer a signal throughout the cell in order to complete a
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cellular event. At certain situations, understanding the flow of these interactions
may become critical or helpful. Therefore we have made use of Paths Of Interest
query approach (Algorithm 3) to develop a query that will answer this need. To
make the premise of query more clear to the user, we have called the query as
“Paths From To”.
Figure 3.8 shows an example result. The source molecule is CASP9 and the
target molecule is CASP3, length limit is 2. With these parameters, ChiBE
returns the requested path in a new view with the result being highlighted. One
point to note here is that Paths From To can only be performed in an entity-based
manner. This is because one cannot distinguish between source nodes and target
nodes when a simple selection on graph is used to specify the nodes of interest.
As the distinction between source and target nodes is not available, we cannot
offer a state-based query for this type.
Figure 3.8: An example result for Paths From To query
3.4.2.1 Alternative Types
In Algorithm 3, we have described a way of implementing Paths Of Interest query.
However, there are also other versions of this query type offered in ChiBE, with
slight modifications.
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One of the changes concerns the determination of search distance limit. In the
original implementation, user is expected to define a positive integer as the limit.
However, there may be cases where the user does not have an idea about the size
of the path. For these situations, we offer a shortest-path based distance limit.
ChiBE first calculates the length of shortest path between the source and target
nodes. Then as the distance limit, the summation of shortest path’s length and
a user defined parameter limit is used. The changes that has been done can be
seen in Algorithm 9. The length of shortest path is calculated by summing the
forward and reverse distance labels of nodes in the candidate set (Line 5) as this
will return the length of the path passing through a node. The minimum of these
summations will give the minimum length of the path that can pass through any
node in the network. With this new distance limit calculation approach, users
can easily recover paths based on the shortest distance between the two sets. Like
Paths Of Interest algorithm, this algorithm’s time complexity is O(|V |+ |E|).
Algorithm 9 PathsOfInterest-Shortest(S, T , limit)
1: C ← BFS(S, ∅, fwd,∞)
2: ResetColor(C)
3: C ← C ∪BFS(T, ∅,rev,∞)
4: R← ∅
5: shortest← minimum(v.label(fwd) + v.label(rev)) where v ∈ C
6: for all node n ∈ C do
7: if n.label(fwd) + n.label(rev) ≤ shortest + limit then
8: R← R ∪ {n}
9: return R
The second modification is about handling the relationships within source set
and target set. Algorithm 10 shows its difference from Algoritm 3. Instead of
calling breadth-first searches with empty target sets, this modified type defines
a search with target sets. This means that the search stops at the first time a
node from the target set is reached during traversal and as a result, the paths
that start from a source (target) node and end at a source (target) node are not
added to the result set. So this query strictly finds the paths from source nodes
to target nodes and ignore relationships observed within sets.
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Algorithm 10 PathsOfInterest-Strict(S, T , limit)
1: C ← BFS(S, T, fwd, limit)
2: ResetColor(C)
3: C ← C ∪BFS(T, S,rev, limit)
4: R← ∅
5: for all node n ∈ C do
6: if n.label(fwd) + n.label(rev) ≤ limit then
7: R← R ∪ {n}
8: return R
3.4.3 Paths Between Query
Paths From To query focuses on paths that follows a particular direction, however
there may be cases where a user is interested in all paths between a set of molecules
rather than a subset of them in a specific direction. The cases where a researcher
is interested in a number of proteins but does not know the true nature of the
relationship between these molecules are suitable candidates for making use of
this query. To provide a solution, we require a query type that finds the paths
between the molecules in a single set, irrespective of path direction and Graph of
Interest query explained in Algorithm 4 is the exact answer to this problem. In
context of ChiBE, this query is called “Paths Between” again to be more clear
about the nature of the query.
The sample pathway view seen in Figure 3.9 is the result of a Paths Between
query, with NBN and MRE11A entities specified as the source set. The length
limit in this case is 2.
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Figure 3.9: An example result for Paths Between query
3.4.4 Common Stream Query
A single transcription factor can regulate the expression of multiple different
proteins. Conversely, a single protein might be regulated through the action of
multiple molecules. The general trend in these cases is that there may be common
molecules in the upstream or downstream of a particular set of molecules. Discov-
ering these common regulators or targets is an important step in understanding
the causative relationships between these molecules. To be able to identify these
paths, we have made use of Commons Stream query described in Algorithm 5.
Example result for this query type can be seen in Figure 3.10, in which
the common downstream of TP53 and ATF2 with distance limit of 3 has been
searched.
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Figure 3.10: An example result for Common Stream query
3.5 Pathway Commons Queries
All of these queries described up to this point are performed on currently loaded
model. This means that the search space is limited to the pathway model that
has been loaded. ChiBE offers another set of queries with a much wider search
space: Pathway Commons Database [9]. Instead of being limited to the model
in hand, users can perform queries to this remote database. Another advantage
is that users can use these queries to obtain a model to start working with when
they do not have a model in hand.
Neighborhood, Paths Between, Paths From To, and Common Stream queries
detailed in Section 2.3 are offered in this set. In local queries, input set of
molecules is selected from the entities found in the model, whereas to perform
Pathway Commons queries, HGNC symbols [26] of molecules need to be supplied.
The remaining set of inputs for queries, such as direction and distance limit, are
similar to their counterparts in local queries. Based on these given inputs and
query type, ChiBE performs searches on the Pathway Commons database using
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these query algorithms. The result is then presented to the user in a new view.
There are two other query types that are performed on Pathway Commons
database, but these are not available for local models. The first one is called
Pathways With Keyword, which as its name suggests performs the query based
on a given keyword. The keyword is searched in the database in order to extract
the pathway models containing the given keyword. The list of pathways obtained
through this search is presented to the user in a dialog. For instance when “EGFR
signaling” is given as the keyword, the list of pathways seen in Figure 3.11 is
obtained from Pathway Commons database. Then user simply needs to choose
one of them for it to be retrieved from the database for visualization. This query
is especially useful for the cases where user is interested in a topic but does not
possess a BioPAX model related to it.
Figure 3.11: A sample result of Pathways With Keyword query
The second query specific to Pathway Commons is called Object With
Database ID. This query asks for the RDF ID of an object of interest and then
retrieves it from Pathway Commons database.
All of these different queries offers users an easy to use connection to Pathway
Commons database. Normally one needs to search a database, download the
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model from the database and then open that model in a tool. However thanks
to these queries, users can perform all of these steps within ChiBE in one click
which eases the process of reaching to a pathway view.
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Chapter 4
High Throughput Data
Integration
Integrating high throughput experiment results, such as microarray or copy num-
ber variation experiments, in an easy and understandable way is an important
step in the analysis of these data in pathway context. This chapter will focus
on the efforts related with the solutions offered by ChiBE to this problem. In
the first section, microarray data integration through GEO database will be dis-
cussed. Then the next section focuses on genomic data integration and the cBio
Cancer Genomics Portal.
4.1 Fetch From GEO
ChiBE 1.0 offers users a flexible and comprehensive feature of integrating exper-
iment results with pathway view. Expression, mass spectrometry, copy number
variation and mutation data can be loaded onto the network after the user has
manually performed a mapping between experiment results and entities in the
pathway view. This manual step of mapping can be overwhelming and may put
off users from utilizing this feature. Therefore, we decided to offer simpler alter-
native with a smaller scope in order to eliminate the need for manual user input
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for successful data integration.
Certain assumptions have to be made to automate this process. One of them
is limiting the type of experiment to expression data. GEO [13] is one of the
most popular databases that has been used to reach to expression microarrays.
It is home to thousands of microarray experiments ranging from cancer vs. tumor
comparisons to expression characteristics of embryonic cells. Because of this, we
chose GEO database for the source of expression data that will be available to
users.
To overlay a particular microarray data hosted in GEO database onto a par-
ticular pathway of choice, the user only needs to supply GEO series ID of the
experiment (Figure 4.1). After that, ChiBE automatically downloads series ma-
trix and platform files from the database. Then, it combines the experimental
values found in series matrix file with the external database reference values found
in platform file into a single XML based file. This file is then used to associate
physical entity nodes of the pathway model with the corresponding experiment
data, based on the mapping between database reference values. One point to
note here is that pathway model needs to be obtained from Pathway Commons
database in order to perform this step successfully. Details of this mechanism
will be explained in the following subsection.
Figure 4.1: Sample “Fetch From GEO” dialog
43
As seen in Figure 4.1, the dialog also displays a list of GEO series IDs. These
are the microarray experiments that have already been downloaded from GEO
database and converted into native format of ChiBE. Considering the fact that
a user might be interested in seeing same microarray data in context of multiple
pathways, the generated files are stored in a local directory to ease their reuse.
The downloaded series matrix and platform files are also stored in this directory.
4.1.1 Implementation of Fetch From GEO Feature
The main steps performed in ”Fetch from GEO” feature offered by ChiBE is
summarized in the Algorithm 11.
Algorithm 11 FetchFromGEO(seriesID)
Require: seriesID is a string starting with “GSE”
1: cedF ile← null
2: if seriesID.ced exists then
3: cedF ile← seriesID.ced
4: else
5: seriesMatrix← GetSeriesMatrix
6: platform← GetPlatform
7: ReadPlatformFile(platform)
8: ReadSeriesFile(seriesMatrix)
9: cedF ile← Finish
10: ColorWithExperiment(cedF ile)
seriesID is the only input required from the user, it stores the GEO series
ID of the experiment of interest. The method first checks the local directory for
an already existing .ced file belonging to this series ID. If found, this .ced file is
directly used to integrate pathway view with the experiment data through color
codes. If ChiBE has not already prepared an experiment file for the particular
experiment, the remaining required steps are performed.
First of all, ChiBE requires series matrix and platform files belonging to the
specified experiment. Lines 5 and 6 refers to these steps. These files are down-
loaded from GEO database, only if they are not already found in the local di-
rectory. The elapsed time for download will depend on the size of these files, so
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storing them in a local directory will eliminate spending extra time if the user
wants to reuse the same experiment for more than once. When we ensure that
both series matrix and platform files are ready for use, method’s first action will
be obtaining header lines from both platform and series matrix files. As it can
be seen in the line highlighted in red in Figure 4.2, each platform file contains
a particular header line which lists the reference types stored in the platform
file. In this example, we can see “Gene Symbol” or “ENTREZ GENE ID” of the
particular gene, with the identifier of microarray probe stored in “ID” column.
ReadPlatformFile method extracts these reference names from the platform
file. Additionally, this method is also responsible for automatically finding the
matches between the reference list found in platform file and the known reference
set stored by ChiBE. ChiBE stores a mapping between known database names
and their synonyms commonly encountered in platform files to describe these
databases (Figure 4.3). So ReadPlatformFile method finds the reference
names that have counterparts in the knownn reference set in order to identify
columns of platform file that will be used in the upcoming steps.
Figure 4.2: A portion of a platform file GPL96
Similar to platform files, series matrix files also contain informative lines re-
lated to contents of the file before the actual experimental values begin (Fig-
ure 4.4). In this example, first column contains the probe identifier and the up-
coming columns hold GEO accession values for each different experiment found
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Figure 4.3: A portion of known reference set that is stored in ChiBE listing the
generic name and synonyms for popular references
Figure 4.4: A portion of a series matrix file GSE6014
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within GEO series. ReadSeriesFile method extracts this header line to iden-
tify the column that contains the probe identifier values and the columns that
contain actual experimental values. One point to highlight is the matching be-
tween probe identifier columns of platform and series matrix files. Thanks to the
use of same identifiers for same probes, we can link the experiment values found
within series matrix files to external references stored in platform files.
After these preliminary steps, the critical work is performed in Finishmethod,
whose basic steps are highlighted in Algorithm 12.
Algorithm 12 Finish
1: experiment← CreateExperimentData
2: FillInReferences(experiment)
3: FillInDataValues(experiment)
4: ClearUselessRows(experiment)
5: if experiment is not empty then
6: cedF ile←WriteExperimentData(experiment)
7: return cedF ile
ChisioExperimentData(.ced) file generated at the end of this process is an
XML based file (Figure 4.5). So as the first step, an XML object experiment
is created to be filled in during the upcoming steps. Each row in it corresponds
to a single microarray probe and the methods found in Finish are responsible
for filling up ref and value tuples of every row. We have already obtained the
matching of reference names between platform file and known reference set with
ReadPlatformFile (Line 6 in Algorithm 11). FillInReferences method
uses these reference columns in order to fill reference values for each row of re-
sulting .ced file. For each probe, it consults the platform file to get the values of
selected references and then stores them as ref values, as seen in Figure 4.5. After
filling reference values for each microarray entry, Finish then moves on to actual
experiment values with FillInDataValues method. As explained previously,
platform and series matrix files contain equivalent probe identifiers and these will
be used at this step to associate experimental values with rows already possessing
reference values. The number of value tuples found in each row is specific to the
number of experiments found in the original series matrix; each experiment is
integrated separately. At the end of these steps, two separate files that we had
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at the beginning gets merged into a single structure that is easy to use in the
upcoming processes. Then ClearUselessRows is called to get rid of the rows
in experiment object that lacks either reference or experimental values. Final
step of this method is writing of this XML object into a .ced file, provided that
experiment object actually contains reference and experimental values.
Figure 4.5: A portion of .ced file highlighting its components
With this step finished, microarray experiment result stored in GEO database
has been automatically converted into an XML based .ced file, without causing
any practical concern to user apart from supplying a series ID. One point to note
here is that the generated .ced file is independent of currently loaded pathway
model onto which data will be overlayed. There is no a dependency to information
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stored in pathway model at any step of this process. Thanks to this, once a .ced
file is created for a particular microarray experiment, it can be integrated with
any pathway model ensuring the reusability of the files.
Figure 4.6: Example pathway view with microarray data (GSE6014) mapped
onto the pathway objects
The final act to complete data integration is to match these experiment values
in .ced file to the nodes in the pathway and to update color of each node based
on the experiment results. This step is handled by ColorWithExperimen-
tAction method, which maps the experiment values to the nodes in the graph
based on reference values of each node. Each node possesses entries of certain
external databases and the overlap between these set of reference databases with
the ones in the platform file is used to identify the node that a microarray probe
corresponds to. An example result can be seen in Figure 4.6, in which pathway
named “Activation of Pro-Caspase 8” is integrated with GSE6014. Tooltip of a
node is updated to contain the experimental value and color of the node is up-
dated based on a predefined color code. Shades of red are used for positive values
and shades of blue are used for negative values, darkness of which corresponds
to the magnitude of the experimental value. The specific subset of experiments
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that are used to calculate these experimental values is user-dependent. From all
the available experiments found within a series matrix files, the user can choose
a subset of them or all of them to visualize. If that is the case, their average is
calculated as the final experimental value. Users can also perform comparisons,
if they choose two different sets of experiments. To reflect the comparison, log-2
ratios of the averages of the experiments found in each set is calculated.
As it can be seen, this new feature integrates expression microarray data with
the pathway view seamlessly and without being a burden to the user. This ease
of use will help to remove the barriers in analysis of expression data along with
pathway knowledge.
4.2 Fetch From cBioPortal
The cBio Cancer Genomics Portal, shortly the cBioPortal, [14] is a web based
source that provides in depth analysis for cancer genomics data. With the ad-
vences in genomics technologies, TCGA and similar community efforts have been
trying to unravel the mysteries of cancer cells in genome level by sequencing their
genome and searching for alterations at nucleotide and expression level. These
efforts in turn have led to the requirement for tools to analyze the vast amount of
data that has been generated through the experiments. The cBioPortal has been
developed to answer these needs. The portal currently hosts data for more than
30 cancer genome datasets, with the number increasing based on the availability
of new experiments. For these cancer samples, it offers a variety of data including
DNA copy number, mutations, mRNA expression, microRNA expression, phos-
phoprotein level (RPPA) and DNA methylation data. ChiBE offers a gateway for
the cBio Cancer Genomics Portal, in order to integrate it with powerful pathway
knowledge. With the cBioPortal, users can see the alterations at genomic and
expression level for each gene. By connecting ChiBE to the portal, we are offering
the possibility of an analysis at pathway level. This way, users will be able to
see the roles of highly altered genes in critical biological pathways or search for
driver mutations in known cancer pathways.
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ChiBE uses web service interface offered by the cBioPortal in order to retrieve
required data from portal. The user is required to determine three parameters
in order to use this feature (Figure 4.7). The first one is the cancer study (Fig-
ure 4.7(a)). All available cancer studies are listed in a drop-down menu and the
user is expected to choose one of them. Based on this selection, the choices for
second parameter - which is case list - are updated. This option allows the user
to decide subset of samples to focus on (Figure 4.7(b)). For instance, one may
choose to see the experimental results only for tumors with sequencing and aCGH
data or all of the available tumor samples. After this, the only remaining input
is the genomic profile (Figure 4.7(c)). At this step, the user is required to se-
lect type of experimental results that s/he wants to retrieve from the portal, for
instance copy number alterations or mRNA expression or mutations. Selection
of multiple genomic profiles is possible at this step, in that case the combined
results for all selected profiles are calculated.
After these selections are completed, ChiBE requests the specified data from
cBio Cancer Genomics Portal through its web service interface. The specific
experiment results for the specified subset of cancer dataset are then used to
calculate alteration percentage of each gene found in the pathway model. For this
purpose, certain thresholds are determined in order to determine a gene’s status
as altered based on the experimental values. Figure 4.8 reflects the predefined
values for these thresholds. For instance for a gene to be labeled as altered, its
expression value has to be greater than 2.0 or smaller than -2.0. These thresholds
can be updated by the user through “Settings” dialog available in cBio Portal
parameter selection dialog (Figure 4.7).
Similar to the integration of GEO data, ChiBE requires an external reference
to map data obtained from cBio Portal to the nodes found in the pathway model.
However, in this case this reference matching solely depends on HGNC gene
symbols [26]. HGNC IDs of genes found in the pathway are first obtained and
then these are used to retrieve experimental results from the portal. For each
gene, the values are gathered for each sample of the specified case list. Then
based on the thresholds (Figure 4.8), a binary decision is made. If the gene is
found to be altered in the particular sample, its value becomes 1.0. If it is not
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(a) Cancer study selection
(b) Case list selection
(c) Genomic profile selection
Figure 4.7: cBio Portal parameter selection dialog
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Figure 4.8: cBio Portal Settings dialog where you can adjust thresholds for dif-
ferent data types
altered, then the given value is 0. After this conversion is done for every sample
in the case list, the average is calculated to determine the final alteration value
for that particular gene. After every gene’s alteration percentage is calculated,
new coloring is performed on the pathway view based on the color codes reflecting
this alteration values (Figure 4.9). Again, tooltip of each physical entity node
displays this final value.
Additional insight into this alteration value is provided through the cBioPortal
data details dialog that is offered in pop-up menu of physical entity nodes. As it
can be seen in Figure 4.9, this additional dialog gives detailed information about
alteration status of a particular gene. When multiple genomic profiles are loaded,
it separately provides information for each of them and for their cumulative result.
In addition, the percentage of alterations whose outcome is known - activating or
inhibiting - are separately given to enhance analysis.
With this new feature, users can integrate genomic status of a specific cancer
with any pathway data they choose in one click, and then analyze how these
alterations can cause disturbances in biological interactions.
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Figure 4.9: A sample pathway overlayed with data from the cBioPortal, also
exemplifying the cBioPortal Data Details Dialog of a selected node.
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Chapter 5
Further Improvements
This chapter discusses miscellaneous additional changes done in ChiBE with ver-
sion 2. First, a new connection offered to DAVID database will be described.
Then, the updates in visual notation of ChiBE that has been done to increase
compatibility with SBGN notation will be presented.
5.1 Connecting to DAVID
The Database for Annotation, Visualization and Integrated Discovery (DAVID)
[15] is a popular web portal that has been designed to offer biological research
community ways of annotating and understanding functionalities and properties
of sets of genes and proteins. The target of the tool is gene or protein lists that
has been identified by researchers to be related with each other. Then, this list
is supplied to DAVID, in order to perform analysis that will provide more insight
into the elements of the list and give clues about their relationships. One of the
main features is identification of Gene Ontology [27] terms that are commonly
observed within the list. Based on these Gene Ontology terms, DAVID can also
perform clustering of this list into highly related groups.
While performing their analysis in ChiBE, users may in the end reach to
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a set of molecules that they are interested in. They would like to know more
about this set of molecules in order to understand why their analysis has revealed
this particular set of molecules. For this purpose, DAVID might be a useful
tool. However, to be able to use DAVID to annotate the result set, users need
to first identify the IDs of these molecules as DAVID requires unique IDs of
genes/proteins from a particular type as its input. Manually identifying the
specific ID of each molecule and then combining them to supply to DAVID may
be a long and demanding task, especially when the set of molecules is large. To
overcome this obstacle, we offer an easy-to-use connection to DAVID to open new
ways of analysis to the user.
This new feature called “Connect To DAVID” will take the set of molecules
from the user and then automatically direct them to DAVID to see the result
of analysis. User first needs to select nodes of interest from the pathway view.
Then, clicking on “Connect To DAVID” item under “Data” menu of the top
menubar will open a dialog that will list the available analysis options offered
by DAVID (Figure 5.1). There are four different options related to the features
offered by DAVID. “Functional Annotation” option will perform annotation en-
richment analysis, in order to identify Gene Ontology terms that are found to
be significantly enriched in this gene set. “Gene Functional Classification” di-
vides the list into clusters based on the functions and annotations of the elements
within. To get extensive information about each gene, “Gene Report” can be
used. “Gene Name Batch Viewer” lists each gene along with its identification ID,
species and genes related to it.
Based on the selection performed, a URL following DAVID’s API service [28]
syntax will be automatically prepared. For this URL, ID of each selected node
is required and it is automatically extracted by ChiBE from the information
associated with each node. No user input is required to find IDs of selected
nodes. Then, the user will be directed to this URL to reach to the result of the
analysis. Figure 5.2 gives an example result when “Gene Name Batch Viewer”
option is selected with the nodes selected in Figure 5.1.
With this feature, a quick connection to DAVID database is offered in order
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Figure 5.1: A sample pathway image used to connecting to DAVID, along with
the dialog that will be used for selection of analysis option.
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Figure 5.2: The result of “Gene Name Batch Viewer” analysis
to ease the annotation of genes or proteins of interest that has been obtained
through the use of other features of ChiBE.
5.2 SBGN-PD Notation
SBGN community has developed three different notation specifications for vi-
sualization of biological pathways and one of them - process description [16] -
is relevant to our purposes. Process description language has been designed to
visualize biological reactions and interactions occurring in a cell with spatial in-
formation and temporal flow of events. This specification is compatible with
the type of information that ChiBE is designed to present. Although following
a similar reasoning to process description diagrams, previously ChiBE had its
own visual notation not following the SBGN standard. With version 2, ChiBE
now mostly complies with SBGN process description (SBGN-PD) notation (Fig-
ure 5.3). This will decrease the adaptation period of new users, who are already
familiar with SBGN notation, to ChiBE.
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Figure 5.3: SBGN-PD’s visual notation (modified from [16])
The updated set of nodes and edges used by ChiBE can be found in Figure 2.2.
Just like SBGN-PD, ChiBE uses rounded rectangles to signify macromolecules.
However, there is a difference in visualization of small molecules (simple chemicals
in SBGN-PD). SBGN suggests use of circles for their display, but label placement
in a circle is not as effective as label placement in a rounded rectangle. There-
fore, ChiBE uses rounded rectangles also for visualization of small molecules. The
differentiation with macromolecules is ensured by coloring. Small molecules are
always white, whereas each macromolecule is given a different color during visual-
ization. Clone markers are recently added in order to emphasize the cases where
a small molecule is found ubiquitously in a pathway. Multimer visualization has
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also been updated to follow SBGN-PD guidelines.
Changes in the visualization of edges have also been done. Previously, ChiBE
was using color code to differentiate the roles of edges: green for activating rela-
tionships, red for inhibiting relationships and black for the remaining. We have
merged this color code with the suggestions of SBGN-PD notation. The red in-
hibition edge’s arrow type has been updated. Green activating relationships has
been divided into two as simulation and catalysis, adding different edge types for
these two. As SBGN suggests, a modulation edge has also been added. Different
from SBGN notation, ChiBE has one more edge type called “member of”, as this
relationship does not have a counterpart in SBGN standards. It is used to repre-
sent generic relationships between physical entities and visualized with a specific
colored dashed edge.
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Chapter 6
Example Results
In this chapter, we will be exemplifying the features of ChiBE discussed in pre-
vious chapters as use cases in the analysis of biological pathways.
6.1 From Pathway View to Genes of Interest
We will start this example with a relatively complicated pathway view and try to
reach to a set of genes that may be significant through integration of experimental
results. The focus of the analysis will be liver cancer. Some cancer cases are
associated with disruptions in particular pathways that are critical to survival
of cells. These disruptions include mutations or copy number variations that
affect a gene at the critical point of the pathway, so when it is not functioning,
remaining of the pathway collapses. Alternatively, changes in expression of genes
causing under or over-abundance of proteins may cause significant dysregulations
in pathways. Identifying these dysregulated genes can help scientific community
to better understand the mechanics of the disease or to develop treatments and
with this example, the aim will be using ChiBE to discover problematic genes
hidden in a cellular pathway that is known to be associated with disease. For
instance, Fibroblast Growth Factor (FGF) signaling pathway has been identified
to be associated with liver cancer [29] and so this pathway will be the focus of
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analysis to see whether there are genes that are misbehaving in the context of
liver cancer.
To start our analysis, we first perform Pathways With Keyword query on
Pathway Commons database with “FGFR” as the keyword. The pathway named
“Signaling by FGFR” seems to be a good fit for our purpose, so it is selected for
download from Pathway Commons database.
The first line of analysis can be integration of this pathway view with expres-
sion data. Liao et al. have performed microarray analysis in order to decipher
the gene expression profiles of normal and tumorigenic liver tissues [30]. This
dataset can be a useful experiment to understand the expression differences be-
tween cancerous and normal tissues in the context of FGFR signaling pathway.
To integrate the result of this experiment with the pathway model obtained from
Pathway Commons, we can use “Fetch from GEO” feature, with the GEO series
ID of GSE6222. Then, we specifically assign normal tissue samples to one set
and cancer samples to another set in order to make a comparison between them
through calculation of log2-ratios. The resulting view, in which experimental
values are reflected with coloring of the nodes, can be seen in Figure 6.1. Shades
of red correspond to cases where the average expression in tumor samples are
higher than the average expression in normal samples and converse of it is valid
for shades of blue.
In analysis of expression values, generally, outlier samples have importance
compared to the average samples. Therefore, we would like to see which entities
in the view have the highest and lowest values when tumor and normal samples
are compared. To identify these entities in the network, we can use “Highlight
With Data Values” feature of ChiBE. By using the dialog seen in Figure 6.1, the
threshold for highlighting is first set to the maximum value possible, which in
this case is equal to 62.34. As a result, IL17RD has been identified as the entity
with highest tumor-to-normal expression ratio (Figure 6.2). This large number
means that this gene is significantly overexpressed in tumor samples compared
to normal tissues. Then, the threshold is set to the minimum value possible of
-6.03. MAP2K1 is found to be the entity possessing this value (Figure 6.2). In
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Figure 6.1: Signaling by FGFR pathway is integrated with expression data.
“Highlight With Data Values” dialog can also be seen, reflecting the smallest
and largest expression values found in the experiment.
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contrast to IL17RD, MAP2K1 is significantly downregulated in tumor samples
as its expression value is higher in normal samples.
Figure 6.2: IL17RD and MAP2K1 entities, which are highlighted in yellow, are
found to be the outliers of this expression dataset.
Genomic status of this network can also possess interesting information. To
perform this analysis, “Fetch From cBio Portal” feature will be used. From
the cBioPortal, we would like to obtain genomics data of a liver cancer related
experiment. Cancer Cell Line Encyclopedia cancer study set [31] has a case
list specific for liver cancer and putative copy-number alterations and mutation
genomic profiles from this case list are chosen for integration with pathway view.
The result of this integration can be seen in Figure 6.3. Shades of red are used
in order to represent the percentage of alteration observed in each gene.
Similar to the previous case, we can use “Highlight With Data Values” feature
in order to find out the entity which has been altered in most of the liver cancer
samples. As it can be seen in the dialog in Figure 6.3, this value is 0.36. The entity
possessing this alteration percentage is EGF. As seen in data details dialog found
in Figure 6.4, the majority of alterations that this gene undergoes have inhibiting
effect meaning that in 32% of these cancer samples, EGF is not functioning
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Figure 6.3: Signaling by FGFR pathway is integrated with alteration data. “High-
light With Data Values” dialog can also be seen, reflecting the smallest and largest
alteration percentages found in the experiment.
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properly due to inhibiting genomic events.
Figure 6.4: EGF, which is highlighted in yellow, is found to be the entity with
highest alteration percentage. The details of genomic changes observed in EGF
can be seen in “EGF: Data Details” dialog.
At the end of these high throughput experiment result integration steps, we
have identified couple of genes that possess significant results within all different
genes found in “Signaling by FGFR” pathway. From this point on, one can
perform a “Paths Between” query using these three entities to see whether or not
there are paths that connect them in a meaningful way, explaining why they are
outliers in these experimental results. Alternatively, we can perform a functional
annotation analysis in order to get a better understanding of the roles of these
proteins and to identify the annotations that are common to them. For this
purpose, we can use “Connect To DAVID” feature of ChiBE. Upon selection
of the three entities on the view, we choose “Functional Annotaion Summary”
option offered by “Connect To DAVID” feature. A subset of the result of this
analysis can be seen in Figure 6.5. The results are sorted in ascending order
based on Benjamini corrected p-values, placing the most significantly enriched
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annotation at top.
Figure 6.5: A portion of the result of functional annotation analysis performed
with DAVID using IL17RD, MAP2K1 and EGF
This example demonstrates a way of using different querying and data inte-
gration options of ChiBE in order to get a better understanding of a complex
biological network in the context of a specific disease. The features described
here can be combined in any way that is suitable to the user’s needs, in the end
to perform a user friendly and thorough analysis of the network of interest.
6.2 Comparison of Experimental Results
ChiBE can also be used to reproduce results obtained through experimental pro-
cedures in order to be able to place them into a pathway context, to discover
relationships that might have been missed or to compare results of different ex-
periments.
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In numerous articles, it has been emphasized that the signaling path from
CDKN2A to RB1 proteins is affected by mutations that disrupt its functionality
and contribute to development of cancer [32, 33, 34]. Glioblastoma [32] and
ovarian serous cystadenocarcinoma [33] are two of the cancer types affected by
this dysregulation. Alterations in a common pathway does not necessarily mean
that the specific changes in particular elements are the same. So, in this example,
we will compare the same path in the context of these two different studies, in
order to see whether there are significant differences between the disruption of
the same path in different cancers.
For this purpose, we first start by obtaining the path from CDKN2A to RB1.
Performing Paths From To query on Pathway Commons Database is a proper
choice to obtain such a path. Length limit is set to four. Then alteration data for
these two cancers are integrated with the pathway view, through Fetch From cBio
Portal feature. For glioblastoma, “Glioblastoma(TCGA, Nature 2008)” cancer
study is selected. As case list, “Tumors with sequencing and aCGH data” is
chosen. Putative copy-number alterations and mutations are selected as genomic
profiles. “Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)” study is
also loaded with the same case list and genomic profiles.
Figure 6.6 reflects the alteration status of glioblastoma samples. CDKN2A
has a high rate of alteration (%46.2), which is mostly dominated by inhibiting
copy number changes. RB1 has a lower percentage of alteration (%11) and in this
case, inhibiting mutations are in the majority. The remaining of the pathway has
either none or low alteration, except for CDKN2B. The values for ovarian serous
cystadenocarcinoma study can be seen in Figure 6.7. The level of alteration in
RB1 is similar to glioblastoma samples but there is a significant reduction in the
case of CDKN2A. In only %2.5 of ovarian serous cystadenocarcinoma samples,
there is an alteration in CDKN2A. Again, like glioblastoma samples, inhibiting
alterations are dominant. From this, one could infer that the dysregulation ob-
served in this path is related to the proteins losing their ability to function as
opposed to being over-active.
Compared to glioblastoma samples, the amount of participants of the path
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Figure 6.6: Path from CDKN2A to RB1 is integrated with alteration values of
glioblastoma samples.
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Figure 6.7: Path from CDKN2A to RB1 is integrated with alteration values of
ovarian serous cystadenocarcinoma samples.
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that are altered is higher in ovarian serous cystadenocarcinoma samples. One
point to highlight in these differences is TP63. In glioblastoma samples, no al-
teration is observed in this gene. However, in ovarian serous cystadenocarcinoma
samples, it is altered in %14 of the samples. More importantly, TP63 forms a
complex with CDKN2A which has RB1 in its downstream (highlighted in yellow
in Figure 6.7). This means that although CDKN2A is altered only in a limited
set of samples, the same path can still be disturbed in a higher amount of sam-
ples due to the alteration observed in its partner TP63. In the original articles,
authors have focused on cyclins and cyclin dependent kinases as the intermediate
molecules between CDKN2A and RB1 [32, 33]. However with this pathway anal-
ysis, a potential role for TP63 gene is identified. Thanks to ChiBE, we have not
only compared two different cancer samples in the context of the same pathway
but also identified molecules that can be further investigated while studying these
cancer sets.
6.3 Expansion of Experimental Results
In this example, a case where analysis performed in ChiBE can help us identify
cases that have been missed during experimental procedures is found [35]. We
focus on a research on endometrial carcinoma performed by The Cancer Genome
Atlas Research Network [36].
Through genomic, transcriptomic and proteomic profiling of tumor samples,
researchers identified a path of interest that has been associated with alterations
that might have significance in the cancer development (Figure 6.8). We first
start our analysis by reaching to a pathway view that represents its first step,
from ERBB2 to KRAS. For this purpose, Paths From To Pathway Commons
query is used, with length limit 1.
The result of this query can be seen in Figure 6.9. From these paths, one of
them specifically gains our interest. The path highlighted in yellow is interesting
because it focuses on transfer of a GTP molecule to a RAS family protein and
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Figure 6.8: A simple network displaying the identified path along with alteration
percentages [35]
this reaction is catalyzed by a complex containing ERBB2. To see whether this
reaction is really significant and holds an interesting result for the analysis, we
load genomic alteration data associated with endometrial cancer. Again, “Fetch
From cBio Portal” feature is used to retrieve the genomic status of endometrial
cancer cells. Uterine Corpus Endometrioid Carcinoma (TCGA, Nature 2013) is
the name of selected cancer study and “tumors with sequencing and aCGH data”
is the case list. “Mutations” and “putative copy-number alterations” are selected
as genomic profiles as we want to focus on the changes that has occurred at
genome level. The results are reflected in the color codes (Figure 6.9).
As it is apparent from the coloring, all members of the complex containing
ERBB2 undergo genomic events in case of endometrial cancer. Although only
ERBB2 is mentioned in the original study [36], ERBB3’s alteration percentage
is equal to ERBB2’s which is %10. When genomic status of all components
of the complex is considered, it can be seen that at least one member of this
“ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1” complex is altered in %35
of cancer samples. Confirming their findings, KRAS is found to have a high rate
of alteration. In fact, with %22 alteration, it has the largest value in this network.
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Figure 6.9: The paths from ERBB2 to KRAS with length 1 are integrated with
alteration data of endometrial cancer.
With this approach of analysis, we have been able to reproduce the results
identified through experiments in silico. We have found a path starting from
ERBB2 and ending at KRAS with both of the molecules having significant al-
teration percentages. On top of this, we have identified that 5 additional genes,
sharing the same complex structure with ERBB2, also are altered in case of en-
dometrial tumors. This finding have expanded the findings of the original paper
as it has identified molecules that are in a similar situation as ERBB2. This
can in turn open ways to new hypotheses in which focus of research shifts from
ERBB2 to the other genes if ERBB2 is not suitable for handling the problem in
hand.
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Chapter 7
Conclusion
ChiBE is an open-source tool that is specialized in visualization, manipulation
and analysis of BioPAX formatted pathway data [3]. This thesis has focused on
the expansion of its capabilities by enriching its querying facilities and improving
integration with various genomics-oriented databases.
The large set of available querying options is a valuable addition to the tool as
it will help users to enhance their analysis by focusing on specific sets of molecules.
The huge and complicated pathway views often confronted during the analysis
of critical cellular events pose a problem when a thorough analysis of the view
is required. The query options will come in handy in these cases as it will help
users to extract knowledge that has been buried in the complex pathway model.
Different types of queries ranging from neighborhood to compartment query will
be at their service based on their specific needs.
Moving the analysis of high-throughput experiments from gene-specific level
to a pathway level can open up new insights into analysis of these experiments.
So offering a way of pathway-level analysis is a significant contribution to the
range of analysis options available in ChiBE. From wide-range of available ex-
periment types and result sources, we have focused on two popular ones: GEO
and the cBioPortal. From GEO, users can easily obtain expression microarray
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data and then integrate the results with the pathway view. A similar, easy-to-
use connection is also offered to the cBio Cancer Genomics Portal, this time in
order to retrieve genomic status of cancer cells. This knowledge is reflected on
the pathway view through the percentages of cases, where the particular gene is
found to be altered. Both for GEO and the cBioPortal data integration, color
codes are used, which makes it easy to distinguish the significant results through
their darker coloring. Overlaying these experiment results through color codes
enables users to understand spatial organization of significant results and help
them to identify causative relationships that arise due to disruptions that has
been identified through experiments.
Convenient access to another external database has also been added. DAVID
database works on a list of proteins and genes, whose main offering is the anno-
tation of the elements of this set with biological themes, such as Gene Ontology
terms. ChiBE now has seamless connection to DAVID with the set of nodes se-
lected on the view. This way, users can identify the biological themes that are
associated with their specific set of entities or see which terms are significantly
enriched within their set.
Finally, ChiBE’s visual notation has been revised to mostly comply with the
community standard of SBGN process description notation. As a result, new
users who are already familiar with SBGN notations should have less trouble
adjusting to ChiBE’s visual notation. To stay up-to-date with the developments
in standards, support for Level 3 models of BioPAX format [1] is also added. Users
now are able to visualize both Level 2 and Level 3 BioPAX models seamlessly.
Collectively, all these improvements have expanded the functionality and
scope of the tool. ChiBE is now a unique software that can access popular
external databases for pathway data models or experiment results and offer a
wide range of analysis tools for pathways stored in standard BioPAX format.
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7.1 Comparing ChiBE with Other Tools
At its current state, ChiBE has earned a unique place in pathway visualization
and analysis fields, which becomes apparent when its functionalities are compared
with similar tools.
CellDesigner [25] can display rich pathway information, similar to ChiBE.
However, it cannot work with BioPAX formatted pathway data. It is designed
for SBML files. Another disadvantage of CellDesigner is that it does not of-
fer graph-based searches. PathVisio [23] can perform integration of experiment
data with pathway view. However, it is limited to expression data and the pro-
cess heavily depends on user input for data mapping, which can be complicated
for most users. PathCase [7] is comparable to ChiBE when its search options
are considered, they offer various query options to users. The narrow focus on
metabolic pathways, however, limits the search space of these queries. Addition-
ally, PathCase does not support integration with experimental results. Cytoscape
[18] visualizes networks with simple interaction views, unless specific plugins are
installed. When compared to ChiBE’s visual notation representing rich pathway
information, this visualization option can offer limited knowledge. Its function-
ality can be extended with specific plugins, but these plugins only offer portions
of ChiBE’s wide range of features.
These examples mean that although different tools can offer certain aspects of
ChiBE’s functionality, none of them can give users the chance of a comprehensive
and integrated workflow like the one offered by ChiBE. With this integrated
workflow, ChiBE can help researchers to generate hypotheses based on their in
silico analyses, which can then be tested experimentally for verification.
7.2 Future Work
Although at this point ChiBE offers a fairly large and an advanced set of features,
new approaches of analysis can be considered for addition. One point can be
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focusing on the properties of these visualized networks. We can look at these
networks from a purely topological point of view, to obtain knowledge that is
inherent to network structure. For instance, global topological properties of the
networks, such as degree distribution or clustering coefficient, can be calculated
to get a grasp of the general organization of the network. They are also useful for
comparing different networks. To get a more detailed look at the local structure
of the network, centrality measures can be calculated. They can offer knowledge
about the critical nodes hidden in the network structure, as these measures can
be used to understand importance of nodes within a network relative to each
other [37]. Addition of these measures that look into a pathway from a graph
theoretical window can bring new insights into the analysis of these biological
networks.
Expansion of the available experimental data that can be integrated with
pathways could be another trail of future additions. On top of GEO and the
cBioPortal, we can provide connections to other data sources. For instance, we
can add ways of integrating high-throughput sequencing experiments, such as
exome sequencing. Additionally, we can refine the current approach we are using
to represent the mutation data with more information. Each mutation will have
different effects on the genes and there already are tools that can predict the scale
of the damage a mutation can cause on a gene. While integrating mutation data,
we can give weights in correlation with the severity of mutations.
As a way of reducing the complexity of the pathway view, we can add filter-
ing features. For instance, after integrating experimental results with the view,
users can be enabled to eliminate nodes that are not within the boundaries of a
threshold.
Another future direction to follow could be transferring the capabilities of
ChiBE to a web-based framework. This will eliminate the requirement for the
user to download and install the tool, which will make the tool available to a
wider audience.
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